**Core Concept**
Thyroxine replacement therapy is a common treatment for hypothyroidism, but it can also be used in certain cases of thyroid cancer. This is based on the concept of "suppressive therapy," where exogenous thyroxine is given to suppress the production of thyroid-stimulating hormone (TSH), which in turn can reduce the growth and metastasis of thyroid cancer cells.

**Why the Correct Answer is Right**
Thyroxine can be given in the case of papillary and follicular thyroid carcinomas, which are types of well-differentiated thyroid cancer. This is because these cancer cells still express thyroid-specific genes and respond to TSH stimulation. By administering exogenous thyroxine, the TSH level is suppressed, which can slow down the growth of these cancer cells. This approach is often used in conjunction with surgery and radioactive iodine therapy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, which do not respond to TSH stimulation. Therefore, thyroxine therapy is not effective in suppressing the growth of MTC cells.
**Option B:** This option is incorrect because anaplastic thyroid carcinoma is a highly aggressive and undifferentiated type of thyroid cancer that does not respond to TSH stimulation. Thyroxine therapy is not indicated in this type of cancer.
**Option C:** This option is incorrect because thyroid lymphoma is a type of cancer that involves the immune system rather than the thyroid gland itself. Thyroxine therapy is not indicated in this type of cancer.

**Clinical Pearl / High-Yield Fact**
It's essential to note that thyroxine therapy should only be used in well-differentiated thyroid cancer under the guidance of an experienced endocrinologist or oncologist. This approach can be effective in reducing the risk of recurrence and metastasis, but it requires careful monitoring of thyroid function and cancer status.

**Correct Answer:** D